Takesue Yoshio, Ohge Hiroki, Sueda Taijiro
Department of Surgery, Programs for Applied Biomedicine, Hiroshima University, Hiroshima, Japan.
Nihon Geka Gakkai Zasshi. 2004 Nov;105(11):709-15.
Three principles must be followed to maximize the benefits of antimicrobial prophylaxis (AMP): 1) use an AMP agent that is bactericidal with a spectrum that covers the most probable intraoperative contaminants; 2) the initial dose of AMP agents should be given no more than 30 min before the skin is incised: and 3) maintain effective levels of antibiotics throughout the surgery and until at most a few hours after the incision is closed in the operating room. These recommendations have become standardized in North America and Europe. A few controversies, however, persist in Japan, especially concerning the duration of AMP. Most practitioners recommend that prophylaxis be continued until postoperative day 3 to 4. However, some authors reported that the administration of AMP agents for 3 to 4 days causes the development of resistant strains. It is thus necessary to formulate national guidelines for appropriate AMP which are validated by the results of randomized, controlled trials conducted in Japan. In the treatment of postoperative infections, Gram-stain-based antibiotic selection is necessary and full knowledge of the interrelationships between pharmacokinetics and pharmacodynamics is important for determining effective regimens. The time that serum levels exceed the minimum inhibitory concentration is the most significant parameter determining the efficacy of beta-lactams, whereas the log area under the curve and peak serum level are the major parameters for aminoglycosides and new quinolones, respectively. Careful application of these concepts should allow surgeons to use more optimal dosing regimens in Japan.
为使抗菌药物预防(AMP)的益处最大化,必须遵循三项原则:1)使用具有杀菌作用且抗菌谱覆盖最可能的术中污染物的AMP药物;2)AMP药物的初始剂量应在皮肤切开前不超过30分钟给予;3)在整个手术过程中以及直至手术室切口关闭后至多几小时内维持有效的抗生素水平。这些建议在北美和欧洲已标准化。然而,在日本仍存在一些争议,尤其是关于AMP的持续时间。大多数从业者建议预防持续至术后第3至4天。然而,一些作者报告称,使用AMP药物3至4天会导致耐药菌株的产生。因此,有必要制定基于日本进行的随机对照试验结果验证的、适用于AMP的国家指南。在术后感染的治疗中,基于革兰氏染色选择抗生素是必要的,并且充分了解药代动力学和药效学之间的相互关系对于确定有效的治疗方案很重要。血清水平超过最低抑菌浓度的时间是决定β-内酰胺类药物疗效的最重要参数,而曲线下面积对数和血清峰值水平分别是氨基糖苷类药物和新型喹诺酮类药物的主要参数。在日本,谨慎应用这些概念应能使外科医生使用更优化的给药方案。